We decided to focus our investigation on the effect of BBR on the TA muscle, despite the observed lack of improvement in functionality, as this muscle type has been studied extensively in preclinical FSHD research [23,24,25,26], and DUX4 transgene recombination in the TA matches what is seen in most muscles/organs characterized by the Jones Lab [22]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.